Insider Transactions in Q1 2025 at Thermo Fisher Scientific Inc. (TMO)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 19
2025
|
Marc N Casper Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
23,736
+16.27%
|
-
|
Feb 19
2025
|
Michel Lagarde Executive Vice President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
9,649
+16.09%
|
-
|
Feb 19
2025
|
Michael A Boxer SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,611
+14.7%
|
-
|
Feb 19
2025
|
Lisa P. Britt Sr. VP and Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,482
+9.61%
|
-
|
Feb 19
2025
|
Joseph R. Holmes VP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
631
+11.87%
|
-
|
Feb 19
2025
|
Gianluca Pettiti Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
8,879
+15.66%
|
-
|
Feb 19
2025
|
Michael D Shafer Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
6,315
+12.82%
|
-
|
Feb 19
2025
|
Frederick M. Lowery Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
6,681
+17.51%
|
-
|
Feb 19
2025
|
Nelson Chai Director |
SELL
Open market or private sale
|
Direct |
16
-0.11%
|
$8,448
$528.09 P/Share
|
Feb 19
2025
|
Karen S Lynch Director |
BUY
Grant, award, or other acquisition
|
Direct |
95
+50.0%
|
-
|
Feb 19
2025
|
Stephen Williamson Sr. VP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,942
+10.22%
|
-
|
Feb 14
2025
|
Marc N Casper Chairman & CEO |
SELL
Bona fide gift
|
Direct |
2,750
-2.72%
|
-
|
Feb 04
2025
|
Gianluca Pettiti Executive Vice President |
SELL
Open market or private sale
|
Direct |
300
-1.8%
|
$175,500
$585.59 P/Share
|
Feb 04
2025
|
Stephen Williamson Sr. VP and CFO |
SELL
Open market or private sale
|
Direct |
9,825
-26.47%
|
$5,747,625
$585.59 P/Share
|
Feb 04
2025
|
Stephen Williamson Sr. VP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,825
+20.93%
|
$2,485,725
$253.99 P/Share
|
Feb 03
2025
|
Stephen Williamson Sr. VP and CFO |
SELL
Open market or private sale
|
Direct |
9,825
-26.47%
|
$5,826,225
$593.13 P/Share
|
Feb 03
2025
|
Stephen Williamson Sr. VP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,825
+20.93%
|
$2,485,725
$253.99 P/Share
|